Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Cardiovascular Medicine|August 3, 2023
Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort studyYun Kyung Cho, Myungjin Kim, Ye-Jee Kim, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 23, 2020
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational StudyYun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 11, 2020
Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World PracticeJiwoo Lee, Yun Kyung Cho, Hwi Seung Kim, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta-analysis with focus on an Asian subpopulationMyung Jin Kim, Yun Kyung Cho, Sehee Kim, et al.
Diabetes & Metabolism Journal|July 22, 2025
New Users of Sodium-Glucose Cotransporter 2 Inhibitors Are at Low Risk of Prostate Cancer: A Nationwide Cohort StudyYun Kyung Cho, Sehee Kim, Myung Jin Kim, et al.
Diabetes & Metabolism|January 9, 2025
New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort studyYun Kyung Cho, Sehee Kim, Myung Jin Kim, et al.
Journal of Neuroengineering and Rehabilitation|August 20, 2014
Facilitation of corticospinal excitability by virtual reality exercise following anodal transcranial direct current stimulation in healthy volunteers and subacute stroke subjectsYeun Joon Kim, Jeonghun Ku, Sangwoo Cho, et al.
Primary Care Diabetes|October 27, 2025
Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM)Min Kyoung Jang, Yun Kyung Cho, Jung Yoon Moon, et al.
Frontiers in Endocrinology|November 17, 2022
Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data studyHwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, et al.
Clinical Endocrinology|December 12, 2025
Real-World Evidence of Long-Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three YearsHwi Seung Kim, Myung Jin Kim, Hee Sung Kim, et al.
Pageof 11